A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s Disease

BACKGROUND: Psychopharmacotherapy currently constitutes the first-line treatment for depression and anxiety in Parkinson’s disease (PD) however the efficacy of antidepressant treatments in PD is unclear. Several alternative treatments have been suggested as potentially more viable alternatives inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Troeung, Lakkhina, Egan, Sarah J., Gasson, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827386/
https://www.ncbi.nlm.nih.gov/pubmed/24236141
http://dx.doi.org/10.1371/journal.pone.0079510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827386/
https://www.ncbi.nlm.nih.gov/pubmed/24236141
http://dx.doi.org/10.1371/journal.pone.0079510

Ejemplares similares